Cost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury

@inproceedings{Kazerooni2010CosteffectivenessAO,
  title={Cost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury},
  author={Rashid Kazerooni and Mark Bounthavong},
  booktitle={ClinicoEconomics and outcomes research : CEOR},
  year={2010}
}
OBJECTIVE There has been growing interest in newer anti-epileptic drugs (AEDs) for seizure prophylaxis in the intensive care setting because of safety and monitoring issues associated with conventional AEDs like phenytoin. This analysis assessed the cost-effectiveness of levetiracetam versus phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury (TBI). METHODS A cost-effectiveness analysis was conducted from the US hospital perspective using a decision… CONTINUE READING
7 Citations
32 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 32 references

Redbook: Pharmacy’s Fundamental Reference

  • T Fleming, ed
  • Montvale, NJ: Thomson PDR;
  • 2008
2 Excerpts

Similar Papers

Loading similar papers…